Hidenori Koyama
Nishinomiya-hama, 6638501, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 98 publications
The mineralocorticoid receptor and its antagonist finerenone regulate hepatic lipid accumulation via the AMPK/SREBP1/FASN signaling.
Journal: Molecular and cellular endocrinology
Published: December 18, 2025
Uric Acid Stimulates PINK1/Parkin-Mediated Mitophagy via Nrf2/HO-1 Pathway to Protect Against Neuronal Apoptosis in Alzheimer's Disease.
Journal: Antioxidants & redox signaling
Published: June 27, 2025
Association of primary aldosteronism with severe sleep apnea and correlation between posttreatment renin activity and amount of change in respiratory event index during sleep.
Journal: Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine
Published: June 26, 2025
Uric Acid Functions as an Endogenous Modulator of Microglial Function and Amyloid Clearance in Alzheimer's Disease.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: June 05, 2025
Activation of mitophagy antagonizes high uric acid-induced hepatic lipid accumulation.
Journal: The Journal of biological chemistry
Published: April 23, 2025
Continuous glucose monitoring-derived time in range is associated with changes in cognitive function test scores in Japanese patients with type 2 diabetes mellitus.
Journal: Diabetes, obesity & metabolism
Published: March 27, 2025
RAGE deficiency obstructs high uric acid-induced oxidative stress and inflammatory response.
Journal: International immunopharmacology
Published: November 26, 2024
High Uric Acid Orchestrates Ferroptosis to Promote Cardiomyopathy Via ROS-GPX4 Signaling.
Journal: Antioxidants & redox signaling
Published: August 08, 2024
Associations of sleep disorders and autonomic dysfunction with cardio-renal function.
Journal: Sleep & breathing = Schlaf & Atmung
Published: April 25, 2024
Internet of things-based approach for glycemic control in people with type 2 diabetes: A randomized controlled trial.
Journal: Journal of diabetes investigation
Published: February 18, 2024
A Case in Which HLA-DR4 is Involved in the Development of Complex Immune-Related Endocrinological Adverse Events following Combination Therapy with Nivolumab and Ipilimumab.
Journal: Case reports in endocrinology
Published: February 17, 2024
Last Updated: 09/26/2026